These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
203 related articles for article (PubMed ID: 8263783)
21. Effects of chelating agents on tissue distribution and excretion of nickel in mice. Xie J; Funakoshi T; Shimada H; Kojima S Res Commun Mol Pathol Pharmacol; 1994 Nov; 86(2):245-55. PubMed ID: 7881873 [TBL] [Abstract][Full Text] [Related]
22. Succimer and the reduction of tissue lead in juvenile monkeys. Smith DR; Woolard D; Luck ML; Laughlin NK Toxicol Appl Pharmacol; 2000 Aug; 166(3):230-40. PubMed ID: 10906287 [TBL] [Abstract][Full Text] [Related]
23. Simultaneous administration of sodium selenite and mercuric chloride decreases efficacy of DMSA and DMPS in mercury elimination in rats. Juresa D; Blanusa M; Kostial K Toxicol Lett; 2005 Jan; 155(1):97-102. PubMed ID: 15585364 [TBL] [Abstract][Full Text] [Related]
24. Effect of L-arginine, dimercaptosuccinic acid (DMSA) and the association of L-arginine and DMSA on tissue lead mobilization and blood pressure level in plumbism. Malvezzi CK; Moreira EG; Vassilieff I; Vassilieff VS; Cordellini S Braz J Med Biol Res; 2001 Oct; 34(10):1341-6. PubMed ID: 11593311 [TBL] [Abstract][Full Text] [Related]
25. Response of lead-induced oxidative stress and alterations in biogenic amines in different rat brain regions to combined administration of DMSA and MiADMSA. Flora SJ; Saxena G; Gautam P; Kaur P; Gill KD Chem Biol Interact; 2007 Dec; 170(3):209-20. PubMed ID: 17870063 [TBL] [Abstract][Full Text] [Related]
26. Monoisoamyl dimercaptosuccinic acid induced changes in pregnant female rats during late gestation and lactation. Mehta A; Pant SC; Flora SJ Reprod Toxicol; 2006 Jan; 21(1):94-103. PubMed ID: 16040228 [TBL] [Abstract][Full Text] [Related]
27. Determination of 2,3-dimercaptosuccinic acid in mice blood and tissues by HPLC with fluorescence detection. Ju XH; Shi Y; Liu N; Guo RC; Wang BJ; Cui X J Chromatogr B Analyt Technol Biomed Life Sci; 2009 Jun; 877(16-17):1621-6. PubMed ID: 19394283 [TBL] [Abstract][Full Text] [Related]
28. A comparison of sodium calcium edetate (edetate calcium disodium) and succimer (DMSA) in the treatment of inorganic lead poisoning. Bradberry S; Vale A Clin Toxicol (Phila); 2009 Nov; 47(9):841-58. PubMed ID: 19852620 [TBL] [Abstract][Full Text] [Related]
29. Determination and metabolism of dithiol chelating agents. XVII. In humans, sodium 2,3-dimercapto-1-propanesulfonate is bound to plasma albumin via mixed disulfide formation and is found in the urine as cyclic polymeric disulfides. Maiorino RM; Xu ZF; Aposhian HV J Pharmacol Exp Ther; 1996 Apr; 277(1):375-84. PubMed ID: 8613944 [TBL] [Abstract][Full Text] [Related]
30. Effect of meso-2,3-dimercaptosuccinic acid on urinary lead excretion in exposed men. Torres-Alanís O; Garza-Ocañas L; Piñeyro-López A Hum Exp Toxicol; 2002 Nov; 21(11):573-7. PubMed ID: 12507251 [TBL] [Abstract][Full Text] [Related]
31. Analysis of meso-2,3-dimercaptosuccinic acid in human urine by capillary electrophoresis using direct injection. Zhu X; Lever SZ Anal Bioanal Chem; 2003 Oct; 377(4):666-9. PubMed ID: 12904952 [TBL] [Abstract][Full Text] [Related]
32. Determination and metabolism of dithiol chelating agents. VII. Biliary excretion of dithiols and their interactions with cadmium and metallothionein. Zheng W; Maiorino RM; Brendel K; Aposhian HV Fundam Appl Toxicol; 1990 Apr; 14(3):598-607. PubMed ID: 2160390 [TBL] [Abstract][Full Text] [Related]
33. Metabolism of meso-2,3-dimercaptosuccinic acid in lead-poisoned children and normal adults. Asiedu P; Moulton T; Blum CB; Roldan E; Lolacono NJ; Graziano JH Environ Health Perspect; 1995; 103(7-8):734-9. PubMed ID: 7588486 [TBL] [Abstract][Full Text] [Related]
34. Oral dimercaptosuccinic acid and ongoing exposure to lead: effects on heme synthesis and lead distribution in a rat model. Pappas JB; Nuttall KL; Ahlquist JT; Allen EM; Banner W Toxicol Appl Pharmacol; 1995 Jul; 133(1):121-9. PubMed ID: 7597702 [TBL] [Abstract][Full Text] [Related]
35. Lipoic acid in combination with a chelator ameliorates lead-induced peroxidative damages in rat kidney. Sivaprasad R; Nagaraj M; Varalakshmi P Arch Toxicol; 2002 Aug; 76(8):437-41. PubMed ID: 12185410 [TBL] [Abstract][Full Text] [Related]
36. Reversal of gallium arsenide-induced suppression of the antibody response by a mixed disulfide metabolite of meso-2,3-dimercaptosuccinic acid. Burns LA; Butterworth LF; Munson AE J Pharmacol Exp Ther; 1993 Feb; 264(2):695-700. PubMed ID: 8382280 [TBL] [Abstract][Full Text] [Related]
37. The influence of chelating agents on the distribution and biotransformation of methylmercuric chloride in rats. Planas-Bohne F J Pharmacol Exp Ther; 1981 May; 217(2):500-4. PubMed ID: 6262488 [TBL] [Abstract][Full Text] [Related]
38. Combined chelation therapy in reducing tissue lead concentrations in suckling rats. Kostial K; Blanusa M; Piasek M; Restek-Samarzija N; Jones MM; Singh PK J Appl Toxicol; 1999; 19(3):143-7. PubMed ID: 10362263 [TBL] [Abstract][Full Text] [Related]
39. The presence of lead decreases the availability of meso-2, 3-dimercaptosuccinic acid for analysis in the monobromobimane assay. Lever SZ; Parsons TL Chem Res Toxicol; 1999 Nov; 12(11):1057-65. PubMed ID: 10563831 [TBL] [Abstract][Full Text] [Related]
40. Pre-clinical evaluation of 2,3-dimercaptosuccinic acid as a radiation nephrotoxicity protective agent during radiopeptide therapy of neuroendocrine malignancy. Moorin RE; Meyrick DP; Rose A Nucl Med Commun; 2007 Apr; 28(4):261-6. PubMed ID: 17325588 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]